Folic Acid Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

Folic acid is produced through a multi-stage chemical synthesis. PNBA is reacted with thionyl chloride in toluene with DMF to form an acid chloride, which reacts with MSG to produce PNBGA; reduction with iron powder and HCl forms PABGA. Separately, acetone is chlorinated with chlorine to produce TCA. PABGA, TCA, and TAPS are then condensed to form the pteridine ring, followed by acidification, crystallization, and purification.

The key feedstocks are PNBA, thionyl chloride, DMF, MSG, iron powder, acetone, chlorine, TAPS, and hydrochloric acid. These materials constitute the principal raw-material cost component of folic acid manufacturing, with PNBA and other synthesis intermediates being major cost inputs.

Asia-Pacific is the dominant manufacturing region, supported by China’s large-scale production base. China accounts for an estimated 40–45% of global folic acid API production capacity, while India is another significant manufacturing and export base.

Folic acid is available in pharmaceutical, food, feed, and high-purity grades. USP specifications require an assay of 97.0–102.0% on an anhydrous basis, while commercial high-purity products commonly specify approximately 98% or higher assay.

Folic acid manufacturing requires cGMP compliance, appropriate pharmaceutical or food-grade quality controls, regulatory filings, and quality assurance. Environmental controls include treatment of hazardous liquid waste and management of HCl, SO2, and unreacted chlorine emissions, as well as proper handling and disposal of iron-containing solid waste.